SEP 4, 2026 · PHASE 1 TRIAL
A Study to Test the Safety, Tolerability and Effect of ZI-MA4-1 for Patients With Locally Advanced or Metastatic Solid Malignancies
ClinicalTrials.gov
First-in-human Phase 1 dose-escalation trial of a novel allogeneic cell therapy with no results yet reported; registration only.
Reported
Estimated enrollment9
PhasePHASE 1
Primary outcome measureSafety and tolerability of ZI-MA4-1, from b…